Uniform protein labeling in intact tissues is a challenge. An approach that allows antibodies to seep within organs could ...

Scientists found that a moderate dose of MEDI8852, an antibody therapy, effectively protected monkeys against severe H5N1 avian flu.

A prophylactic antibody-based immune therapy protects monkeys against severe disease caused by H5N1 avian flu, University of Pittsburgh and NIH Vaccine Research Center researchers report today in ...

New research from the Florida State University Department of Chemistry and Biochemistry shows that a particular type of monoclonal antibody known as NISTmAb retains its structure even if the sugar ...

A prophylactic antibody-based immune therapy has been shown to protect monkeys against severe bird flu caused by H1N1.

From left, Florida State University faculty researcher Fanny C. Liu and Christian Bleiholder, a professor in the Department ...

All nine macaques given the control developed severe disease when exposed to bird flu, as did all given the smallest dose of ...

"This type of prevention can be very useful in controlling infection outbreaks and containing the bird flu pandemic," said an immunologist.

Viruses are masters at disguise. When they are pushed too far by our immune system, they send new virus variants into play ...

The antibody targets a stable part of the bird flu virus, ensuring that the immune protection can resist new variants and offer long-term protection against the globally spreading airborne infection.